C12N 2710/24271
Demonstrated in vivo effect
C12N2710/24271 (Demonstrated in vivo effect) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 4
- Assignees
- 4
- Inventors
- 5
- Latest grant
- 25 May 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Mutant orf viruses and uses thereof19 Jun 2025US 2025/0197815 A9Suzhou Prajna Biotech Co., Ltd.
- Modified parapoxvirus having increased immunogenicity8 Feb 2024US 2024/0043870 A1Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
- Mutant orf viruses and uses thereof26 Oct 2023US 2023/0340424 A1Suzhou Prajna Biotech Co., Ltd.
- Orf virus-based platform for vaccine delivery18 Jun 2020US 2020/0188509 A1Federal University of Santa Maria
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.